…Biobank’ of childhood brain/CNS and solid cancers – including living organoids or lab-grown ‘mini-tumours’ – to trial and develop targeted treatments and improve clinical outcomes, survival rates and quality of…… Read more
…awarded to Dr Paul Daniel from our Centre for Cancer Research. Lions have been involved with childhood cancer since 1976. They have raised more than $13 million for childhood cancer…… Read more
…TIMP pathway that are directly involved with cancer progression and chemoresistance using serous ovarian cancer tumours, ascites cells derived from patients and established ovarian cancer cell lines; to validate candidate…… Read more
…Cancer group investigates how these mutations contribute to disease progression with the aim of developing new therapeutics. Research group Overview The Structural Biology of Inflammation and Cancer Research group focus…… Read more
Professor Ron Firestein is the Head of the Centre for Cancer Research at Hudson Institute of Medical Research. He leads the Cancer Genetics and Functional Genomics research group, and is…… Read more
…lupus CHILDHOOD LUPUS FACTS Differences between childhood and adult lupus Childhood lupus often presents more severe symptoms than adult lupus. The disease tends to progress more rapidly in children. In…… Read more
…our understanding of chemoresistance and metastasis of ovarian cancer. Expertise Female fertility and infertility, ovarian physiology, ovarian cancer Recent Achievements 2014 – Honorary Life Membership to the Endocrine Society of…… Read more
…Inflammation and cancer Inflammatory bowel disease (IBD) Influenza Lung cancer Lupus Microbiome in health and disease Ovarian cancer Pneumonia Stomach cancer Research groups Group heads Groups and research areas Professor…… Read more
…leukaemia, but the unwanted acute and chronic effects of current cancer treatments. Blood cancer 101 Blood cancers arise when blood cells start to grow abnormally and uncontrollably. These abnormal blood…… Read more
Dr Maree Bilandzic is a molecular cancer biologist and ovarian cancer advocate. Dr Bilandzic’s research is focused on addressing a critical ovarian cancer clinical gap. By understanding the key drivers…… Read more
